Willi Miesch

Willi Miesch currently serves as Chairman of the Strategy and Innovation Committee and is a member of the Board of Directors at Medartis, where Miesch has been employed since January 1998. In addition, Miesch is a Board member at Scewo since October 2021 and has been on the Board of Directors for the International Bone Research Association (IBRA) since September 2004. Miesch held the position of Venture Partner at MTIP MedTech Innovation Partners AG from 2016 until December 2023 and served as CEO and a Board member at Nouvag from January 2021 to March 2022. Previous roles include Board member at Osiris Therapeutics from February 2018 to April 2019, Chairman of the Board at Tschudin + Heid AG from 2010 to 2013, and Head of Technical Department & Operations at Villiger Söhne AG from April 1995 to December 1997. Miesch’s early career includes positions such as Head of Operations at Stratec Medical and Operational Manager at Straumann Hägendorf AG. Miesch holds a Bachelor's degree in Business Management from Lucerne University of Applied Sciences and Arts and an Operations Technician TS degree from ABB Technikerschule.